Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Preoperative predictors of endometrial carcinoma in patients undergoing hysterectomy for endometrial intraepithelial neoplasia
Age ≥ 50, postmenopausal status, presence of diabetes and hypertension strong predictors.
»
05/16/25
Mammographic density by time and breast: a retrospective cohort study from BreastScreen Norway
Interaction between time and development of breast cancer positive for absolute and percent dense volume.
»
05/16/25
Fibrogenesis-driven tumor progression in clear cell renal cell carcinoma: prognostic, therapeutic implications and the dual role of neuropilin-1
NRP1 promotes ccRCC proliferation, migration, and invasion by enhancing TGF-β/SMAD-driven epithelial-mesenchymal transition.
»
05/16/25
HBV-driven host chromatin accessibility changes affect liver metabolic pathways, iron homeostasis and promote a preneoplastic phenotype
Upregulation of iron uptake genes leads to significant increase of iron content in HBV-infected PHHs.
»
05/16/25
Emerging roles of ADAM6 and PRSS1 as novel diagnostic/prognostic biomarkers for acute lymphoblastic and myeloid leukemia in adults
Serum levels of ADAM6 significantly higher in ALL and AML patients.
»
05/17/25
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors
Significant increase in EGFR expression in tumor biopsies from NSCLC patients treated with RET inhibitors.
»
05/22/25
Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation
sMRI Cho/NAA > 2x delineates high-risk occult disease.
»
05/22/25
miRNA panel from HER2+ and CD24+ plasma extracellular vesicle subpopulations as biomarkers of early-stage breast cancer
HER2+ and CD24+ EV subpopulations contain complementary biomarkers.
»
05/22/25
Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial
DHA-supplemented group had higher concentrations of stimulated cytokines IL-4, IL-10.
»
05/22/25
Early mortality in patients with cancer and COVID-19 infection treated with immunotherapy
Immunotherapy does not seem to increase risk of 30-day mortality.
»
05/22/25
< Prev
Next >